Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-11-21
DOI
https://doi.org/10.3389/fphar.2025.1713702
Primary Topic
Electrolyte and hormonal disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study

Wen Zhong, Hongzhong Liu, Xin Xiao Zheng, Pei Hu et al.
Frontiers in Pharmacology
Electrolyte and hormonal disorders
article

Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study

Wen Zhong, Hongzhong Liu, Xin Xiao Zheng, Pei Hu, Tao Liu, Ming Rong Liu, Qian Zhao, Jiang Ji, Yishi Li
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Medical Products Administration (CN), Peking Union Medical College Hospital (CN), Fu Wai Hospital (CN)
Otsuka Pharmaceutical, Peking Union Medical College Hospital
Openalex Percentile: Top 49%
Electrolyte and hormonal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study — Wen Zhong, Hongzhong Liu, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS